News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
GSK Bio
NEWS
JOBS
IN THE PRESS
NEWS
Deals
Introducing PfizerKline: Analyst Makes New Case for Merger of GlaxoSmithKline and Pfizer
May 20, 2015
·
5 min read
Deals
Pfizer Will Make $120 Billion Bid for GlaxoSmithKline in Third Quarter, Says Poll
May 13, 2015
·
3 min read
Deals
How GlaxoSmithKline’s Much-Criticized Chief’s Strategy Differs From His Peers
May 11, 2015
·
5 min read
Business
GlaxoSmithKline, University of North Carolina Set Up $20 Million Spinoff to Find a Cure for HIV/AIDS
May 11, 2015
·
2 min read
Meet The Man Who Built A £50 Million Biotech Business
May 8, 2015
·
1 min read
Biotech Bay
Is Novartis AG An Up-And-Coming Cancer Powerhouse?
May 7, 2015
·
1 min read
Business
GlaxoSmithKline Makes Plans for Soon-to-Be Vacant Office Space After Cutting 1,000 Jobs in North Carolina
May 7, 2015
·
2 min read
Business
GlaxoSmithKline Holds Onto HIV Business in Wake of Deals with Novartis AG
May 6, 2015
·
5 min read
Business
As Hampton Takes Over as Chairman at GlaxoSmithKline, CEO Witty Needs to Deliver or “Step Aside”
May 5, 2015
·
7 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee
May 28, 2025
·
9 min read
Press Releases
Vesalius Announces Multi-Target Strategic Alliance with GSK to Develop Breakthrough Treatments for People Afflicted with Parkinson’s Disease
November 12, 2024
·
4 min read
Press Releases
Expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine approved in Canada for adults aged 50-59 at increased risk
November 5, 2024
·
7 min read
Press Releases
GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV Seasons
October 8, 2024
·
10 min read
Pharm Country
GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise
March 7, 2024
·
5 min read
Pharm Country
GSK Announces AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Is Now Available at All Major US Retail Pharmacies
August 17, 2023
·
6 min read
Deals
BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition
May 16, 2023
·
7 min read
Business
AnaptysBio- and GSK-partnered immuno-oncology agent JEMPERLI (dostarlimab-gxly) meets primary endpoint in Phase 3 RUBY trial in primary advanced or recurrent endometrial cancer
December 2, 2022
·
5 min read
